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 Abstract:  The histone variant 2AX (H2AX) is phosphorylated 
at Serine 139 by the PI3K-like kinase family members ATM, 
ATR and DNA-PK. Genotoxic stress, such as tumor radio- 
and chemotherapy, is considered to be the main inducer of 
phosphorylated H2AX ( γ H2AX), which forms distinct foci at 
sites of DNA damage where DNA repair factors accumulate. 
 γ H2AX accumulation under severe hypoxic/anoxic (0.02 % 
oxygen) conditions has recently been reported to follow 
replication fork stalling in the absence of detectable DNA 
damage. In this study, we found HIF-dependent accumula-
tion of  γ H2AX in several cancer cell lines and mouse embry-
onic fibroblasts exposed to physiologically relevant chronic 
hypoxia (0.2 % oxygen), which did not induce detectable 
levels of DNA strand breaks. The hypoxic accumulation of 
 γ H2AX was delayed by the RNAi-mediated knockdown of 
HIF-1 α or HIF-2 α and further decreased when both HIF- α s 
were absent. Conversely, basal phosphorylation of H2AX 
was increased in cells with constitutively stabilized HIF-2 α . 
These results suggest that both HIF-1 and HIF-2 are involved 
in  γ H2AX accumulation by tumor hypoxia, which might 
increase a cancer cell ’ s capacity to repair DNA damage, 
contributing to tumor therapy resistance. 
 Keywords:  DNA damage response;  oxygen sensing;  tumor 
hypoxia. 
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 Introduction: tumor hypoxia and 
therapy resistance 
 Hypoxia is a common feature of solid tumors and develops 
due to inadequate vascularization, tortuous blood vessels 
and high oxygen consumption. Transient blockage of red 
blood cell flux, alternating with rapid alleviation, leads to 
frequent periodical hypoxia/ischemia, followed by reoxy-
genation (Yasui et al. , 2010 ). Reoxygenation, most likely 
mediated by the generation of reactive oxygen species 
(ROS), but not hypoxia can lead to detectable DNA damage 
(Hammond et  al. , 2003a,b ). Hypoxia is strongly assoc-
iated with malignant progression, metastatic outgrowth, 
genetic instability, resistance to radio-and chemotherapy 
and overall poor patient prognosis in various tumor types 
(Brown , 1998 ; Brown and William , 2004 ; Pouyss é gur 
et al., 2006 ). Therefore, a thorough understanding of the 
molecular pathways in the hypoxic tumor microenviron-
ment is warranted to develop new strategies for efficient 
cancer therapy. 
 Central to the cellular response to hypoxia is the 
hetero dimeric hypoxia-inducible transcription factor HIF, 
consisting of one of three oxygen-labile  α subunits and a 
common constitutive  β subunit (Wenger , 2002 ;  Schofield 
and Ratcliffe , 2004 ). HIF activates a large number of 
oxygen-regulated genes required for the adaptation of 
normal cells to hypoxia (Wenger et al. , 2005 ). In tumors, 
HIF-1 is responsible for the generation of new blood 
vessels through transcriptional regulation of the vascu-
lar endothelial growth factor (VEGF), for pH regulation 
by increasing the expression of carbonic anhydrase (CA) 
IX and for the aerobically increased glycolytic capacity of 
cancer cells, also known as the Warburg effect (Seagroves 
et al. , 2001 ; Minchenko et al. , 2002 ; Svastova et al. , 2004 ). 
Furthermore, hypoxic tumor cells are able to maintain 
metabolic functions without an adequate oxygen supply 
via a switch to anaerobic fermentation (the Pasteur 
effect), which is facilitated in a HIF-1 dependent manner 
(Schroeder et al. , 2005 ). Therefore, high HIF-1 levels in the 
hypoxic tumor microenvironment is a well-established 
factor for aggressive tumor growth and a negative factor 
for cancer therapy (Ryan et al. , 1998 , 2000 ; Hopfl et al. , 
2002 ; Unruh et al. , 2003 ). 
 Besides tumor hypoxia, which leads to HIF- α protein 
stabilization, the loss of tumor suppressor proteins, such 
as pVHL, p53 or PTEN, or oncogenes, such as v-src, can 
contribute to high HIF- α levels in cancer cells (Jiang et al. , 
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1997 ; Krieg et  al. , 2000 ; Ravi et  al. , 2000 ; Zundel et  al. , 
2000 ). Both HIF-1 α and HIF-2 α are widely overexpressed 
in many human cancers and are frequently associated 
with malignancy and a poor prognosis (Birner et al. , 2000 ; 
Aebersold et al. , 2001 ). Furthermore, high HIF-1 α protein 
levels have been shown to correlate with incomplete 
responses to chemotherapy and radiotherapy (Aebersold 
et al. , 2001 ; Koukourakis et al. , 2002 ; Bachtiary et al. , 2003 ; 
Generali et al. , 2006 ). Hypoxia  per se affects radiation sen-
sitivity as the radiation-induced DNA damage is dependent 
on oxygen (Gray et  al. , 1953 ). In addition, decreased cell 
proliferation and lower drug concentrations in the hypoxic 
tumor areas contribute to the resistance to chemotherapy. 
However, the underlying molecular mechanisms causing 
therapy resistance of hypoxic tumor cells are incompletely 
understood, but it is likely that HIF downstream targets are 
directly involved in these processes. 
 Targeting HIF to improve cancer 
therapy 
 HIF-1-dependent hypoxic induction of the multidrug-
resistance MDR1 gene was one of the first described 
molecular mechanisms explaining the involvement of 
HIF-1 in chemotherapy resistance in various tumor cells, 
including breast carcinoma, gastric cancer, colon cancer 
and glioma (Comerford et  al. , 2002 ; Wartenberg et  al. , 
2003 ; Zhou et al. , 2005 ; Nardinocchi et al. , 2009 ). Hypoxi-
cally dysregulated apoptosis in response to chemotherapy 
might be another explanation (Erler et al. , 2004 ; Sermeus 
et al. , 2008 ). The role of HIF-1 in the regulation of apop-
tosis is very complex and context specific. The involve-
ment of HIF-1 in apoptosis in certain cell types cannot 
be generalized as cells do not undergo apoptosis under 
degrees of hypoxia sufficient for HIF-1 induction (Wenger 
et  al. , 1998 ). In primary cells, hypoxia typically leads to 
cell-cycle arrest and HIF-1-dependent apoptosis in cases of 
more severe conditions (Greijer and van der Wall , 2004 ). 
However, HIF-1 functions as a robust suppressor of apopto-
sis in most transformed cells. We previously reported that 
transformed mouse embryonic fibroblasts (MEFs) were 
more sensitive to chemotherapy as well as to radiotherapy 
in the absence of HIF-1 α due to an impaired DNA double-
strand break (DSB) repair capacity (Wirthner et al. , 2008 ). 
The underlying molecular mechanism involves markedly 
reduced expression of DNA-PKcs, Ku80 and Ku70, three 
members of the DNA-dependent protein kinases (DNA-
PK), in HIF-1 α -deficient MEFs. Our data were supported 
by a large number of studies that demonstrated reversal of 
radio- and chemoresistance by targeting HIF-1 α in various 
tumor types (Zhang et  al. , 2004 ; Moeller et  al. , 2005 ; 
 Williams et al. , 2005 ; Brown et al. , 2006 ; Li et al. , 2006a,b ; 
Song et  al. , 2006 ; Sasabe et  al. , 2007 ). For example, Li 
et al.  (2006a,b) showed that the knockdown of HIF-1 α in 
breast carcinoma cells repressed G 0 /G 1 -phase accumula-
tion and relieved S-phase block, thereby increasing sen-
sitivity to chemotherapy and attenuating tumor growth 
(Li et al. , 2006a,b ). Functional interference with HIF-1 α in 
various tumor cells has been shown to result in enhanced 
cell death upon treatment with chemotherapeutic agents 
(Ricker et  al. , 2004 ; Peng et  al. , 2006 ; Hao et  al. , 2008 ; 
Sermeus et  al. , 2008 ; Flamant et  al. , 2010 ). However, 
experimentally increasing HIF-1 α enhanced therapy 
resistance (Ji et al. , 2006 ; Martinive et al. , 2006 ). Of note, 
HIF-1 in germ cells of  Ceanorhabditis elegans has recently 
been reported to antagonize p53-mediated apoptosis due 
to DNA damage (Sendoel et al. , 2010 ). 
 The induction of DNA damage by cytotoxic agents 
has proved to be an effective strategy for cancer therapy 
(Einhorn , 2002 ; Agarwal and Kaye , 2003 ; Pires et al. , 2012 ). 
Mutations in DNA damage response (DDR) genes can lead 
to increased frequency and incorrect DNA damage repair, 
thereby contributing to the genomic instability character-
istic for cancer cells (Bolderson et al. , 2009 ). Because HIF-
1-mediated therapy resistance was only observed when 
DSB, but not single-strand break (SSB)-inducing, agents 
were applied, we suspect that HIF-1 might be involved spe-
cifically in DNA-DSB repair (Unruh et al. , 2003 ). 
 The DNA damage response 
in hypoxia 
 Upon DNA damage, histone H2AX is rapidly phospho-
rylated at Serine 139 by ataxia-teleangiectasia-mutated 
(ATM) kinase, ATM- and Rad3-related (ATR) kinase and 
DNA-PK (Fernandez -Capetillo et  al., 2004 ; Zhang et  al. , 
2006 ; Hurley and Bunz , 2007 ). Previous studies have 
suggested that severe hypoxia can elicit a DNA damage-
like response, implying the activation of the ATR and 
ATM pathways and subsequent phosphorylation of H2AX 
(Hammond et al. , 2003a,b ; Bencokova et al. , 2009 ). More 
recently,  Economopoulou et  al.  (2009) identified a novel 
role for histone H2AX in hypoxia triggered angiogenesis. 
Replication specific  γ H2AX was found to be induced in 
an ATR-dependent manner in endothelial cells exposed 
to milder hypoxia (1 % O 2 ). Whether HIF is involved in the 
hypoxic induction of  γ H2AX has not been analyzed so far. 
Therefore, we investigated a potential role for HIF-1 and 
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HIF-2 in the phosphorylation of H2AX under chronically 
hypoxic (0.2 %   O 2 ) conditions. Hypoxic  γ H2AX induction 
was observed in a range of cancer cell lines, was delayed 
in HIF-1 α -deficient MEFs and, after HIF-1 α and HIF-2 α 
knockdown in Hek293 cells, was further decreased when 
both HIFs were downregulated.  Vice versa , in 786-0 cells, 
devoid of pVHL and constitutively expressing HIF-2 α , H2AX 
phosphorylation was increased and could be reversed by 
pVHL reconstitution. These results suggest that HIF plays 
a crucial role in the DNA damage response under hypoxia. 
 Results 
 γ H2AX accumulation in chronic hypoxia 
 Hammond et al. previously reported that severe hypoxia/
anoxia (0.02 % O 2 ) leads to ATR-dependent  γ H2AX accu-
mulation that was attributed to S-phase arrest (Hammond 
et  al. , 2002, 2003a,b ). Because an atmospheric oxygen 
concentration of 0.02 % O 2 results in a tissue partial pres-
sure of oxygen that is most likely below the threshold for 
mitochondrial respiration, we investigated  γ H2AX induc-
tion under physiologically relevant hypoxic conditions. To 
ensure unimpaired mitochondrial respiration, an atmos-
pheric oxygen concentration of 0.2 % O 2 was chosen, cor-
responding to an oxygen partial pressure of approximately 
1.5 mm Hg. Ischemia-like conditions and reoxygenation-
induced ROS formation followed by DNA damage was 
prevented by replacing the cell culture medium every 24 h 
with pre-equilibrated medium and by harvesting the cells 
inside of a hypoxic workstation. Several cancer cell lines 
were exposed to 0.2 % O 2 for 3 – 72 h, followed by analysis of 
H2AX Serine 139 phosphorylation by immunoblotting. 
As shown in Figure  1 A,  γ H2AX accumulated in a time- 
dependent manner in all six cell lines and reached maximal 
induction after 24 – 48 h of hypoxic exposure, depending 
on the cell line. Hypoxic  γ H2AX induction in wild-type 
HEK293 cells with normal p53 was similar to SV40 large T 
antigen immortalized HEK293T cells, suggesting that p53 is 
not involved in hypoxic H2AX phosphorylation. Only wild-
type HEK293 cells were used for subsequent experiments. 
 We next compared  γ H2AX accumulation in hypoxia with 
the effects of the topoisomerase II inhibitor and DSB induc-
ing agent etoposide (Burden and Osheroff , 1998 ).  γ H2AX 
slowly accumulated in hypoxia, reaching a maximum after 
48 – 72 h, and declined after 96 h (Figure 1B). Treatment for 1 h 
with etoposide in concentrations from 0.25 to 8  μ m resulted 
in a similar, dose-dependent increase in  γ H2AX levels. Total 
H2AX levels remained unaffected after both hypoxic expo-
sure and etoposide treatment (Figure 1B). 
 Hypoxic  γ H2AX accumulation is HIF 
dependent 
 The involvement of HIF in hypoxic H2AX phosphorylation 
was investigated by shRNA-mediated stable knockdown 
of HIF-1 α and/or HIF-2 α in HEK293 cells. Hypoxic  γ H2AX 
accumulation was delayed after shRNA-mediated knock-
down of either HIF-1 α or HIF-2 α , with maximal levels only 
after 72 h compared to 24 – 48 h in the parental control 
(Figure  2 A). Total H2AX remained unaffected (Figure 2A). 
Concomitant HIF-1 α and HIF-2 α double knockdowns sub-
stantially decreased hypoxic phosphorylation of H2AX at 
all time points (Figure 2B). 
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 Figure 1   Phosphorylation of H2AX in chronic hypoxia. 
 (A) The indicated cancer cell lines were cultured under 20 % or 0.2 % O 2 conditions for up to 72 h, and  γ H2AX protein levels were analyzed by 
immunoblotting.  β -Actin served as a control for equal loading and blotting. (B) HEK293 cells were exposed to 20 % or 0.2 % O 2 for up to 96 h 
or to various etoposide concentrations up to 8  μ m for 1 h in normoxia. Phosphorylated and total H2AX were analyzed by immunoblotting. 
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 To corroborate these findings, two different MEF cell 
lines derived from two different HIF-1 α knockout mouse 
strains were analyzed. These cell lines were either only 
immortalized by SV40 large T (MEF- Hif1a -/- T) or immor-
talized and transformed by H- ras (MEF- Hif1a -/- r T), 
respectively (Feldser et  al. , 1999 ; Ryan et  al. , 2000 ). 
Importantly, these MEF cell lines were shown to lack 
functional HIF-2 α protein (Park et al. , 2003 ). Confirming 
the results obtained with HEK293 cells,  γ H2AX levels in 
wt MEFs accumulated after 24 h exposure to 0.2 % O 2 but 
were strongly impaired in MEFs devoid of HIF-1 α . Total 
histone levels remained unaffected, as shown by Ponceau 
S-staining of the extracted histone fraction (Figure 2C). 
We previously reported increased susceptibility to DNA 
damage with enhanced phosphorylation of H2AX in MEF-
 Hif1a -/- r T upon low dose (0.5 – 4  μ m ) etoposide treatment 
(h)
(h)
(h)
(h)
Etoposide (8 μM)
Parental Parental
Parental Parental Parental Parental
 Figure 2   HIFs are required for hypoxic  γ H2AX accumulation. 
 (A, B) Parental, shRNA-mediated HIF-1 α or HIF-2 α knockdown (shHIF1A or shHIF2A, respectively) or HIF-1 α /HIF-2 α double knockdown 
(shH1A/H2A) HEK293 cells were grown under 20 % or 0.2 % O 2 conditions for the indicated time points. Phosphorylated and total H2AX was 
analyzed by immunoblotting, and  β -actin served as a control for equal loading and blotting. (C) MEF- Hif1a  + / +  rT, MEF- Hif1a -/- rT, MEF- Hif1a  + / +  T, 
MEF- Hif1a -/- T were exposed to 20 % or 0.2 % O 2 for 4 or 24 h or treated with 8  μ m etoposide for 1 h. Ponceau S staining was used as a control 
for equal extraction and loading of histones. (D) Parental and HIF-1 α /HIF-2 α double knockdown (shH1A/H2A) HEK293 cells were grown 
under 20 % or 0.2 % O 2 conditions for the time points indicated before  γ H2AX levels were analyzed by FACS.  γ H2AX positive cells were gated 
as indicated by the rectangles and quantified relative to the total cell number. (E) 786-0 and 786-0-pVHL cells were grown under 20 % or 
0.2 % O 2 conditions for 24 – 72 h, and  γ H2AX and  β -actin protein levels were analyzed by immunoblotting. 
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(Wirthner et  al. , 2008 ). However, the HIF dependent 
differ ence of  γ H2AX levels decreased with higher doses 
of etoposide and was invisible upon treatment with 8  μ m 
(Wirthner et  al. , 2008 ). In line with these findings, no 
HIF-1 α -dependent changes in  γ H2AX induction could be 
observed after high-dose (8  μ m ) etoposide treatment, 
which resulted in  γ H2AX levels that were only slightly 
higher than the  γ H2AX levels in HIF-1 α positive MEFs after 
24 h of hypoxia (Figure 2C). 
 To further confirm the role of HIF in hypoxic  γ H2AX 
accumulation, parental and HIF-1 α /HIF-2 α double knock-
down HEK293 cells were grown under 20 % or 0.2 % O 2 
conditions for up to 72 h before  γ H2AX levels were quanti-
fied by FACS analysis. Whereas 88 % of parental cells were 
strongly  γ H2AX positive after 48 and 72 h of hypoxia, only 
20 – 24 % of the HIF-1 α /HIF-2 α double knockdown HEKs 
showed similarly elevated  γ H2AX staining (Figure 2D). 
 Finally, VHL-deficient 786-0 cells, containing con-
stitutively stabilized HIF-2 α (Maxwell et  al. , 1999 ) and 
reconstituted 786-0-pVHL cells were cultured under 20 % 
or 0.2 % O 2 conditions for 4 – 72 h and analyzed by immuno-
blotting. In line with our findings above, both basal and 
hypoxic levels of  γ H2AX were substantially higher in 786-0 
cells compared to 786-0-pVHL cells (Figure 2E). 
 Hypoxic  γ H2AX accumulation is independent 
of DNA-DSB formation 
 Hypoxia has previously been suggested to induce genetic 
instability associated with increased HIF-1 α levels (Bristow 
M
ed
ia
n 
ta
il 
m
om
en
t (
%
)
Oxygen (%)
etop (μM)Et
op
os
id
e 
(μ
M
)
 Figure 3   Hypoxia does not induce detectable DNA strand breaks. 
 (A) Representative example of a comet assay. DNA fragmentation in wild-type MEFs was induced by exposure to 1  μ m etoposide for 1 h. DNA 
was stained with SYBR green, and all images were acquired with fixed exposure times. (B) DNA fragmentation was  quantified by  determining 
the median tail moment of at least 150 comets per condition using CometScore software. Data are shown as mean values ± SEM. (top panel) 
Hypoxic induction of H2AX phosphorylation was confirmed by immunoblotting of parallel samples performed as in Figure 2C (bottom panel). 
and Hill , 2008 ). However, the previously published lack of 
detectable DNA damage at 0.02 % O 2 suggests that hypoxic 
 γ H2AX accumulation might be partially or fully independ-
ent of DNA-DSB formation (Hammond et al. , 2003a,b ). To 
directly assess DNA-SSB and DNA-DSB formation under 
0.2 % O 2 conditions, we performed alkaline single-cell 
electrophoresis (comet assays) in wild-type and HIF-1 α -
deficient MEFs and concomitantly determined  γ H2AX 
protein levels by immunoblotting. As shown in Figure  3 A, 
the emergence of DNA-DSB induced by 1  μ m etoposide 
could be visualized reliably by  ‘ comet halo ’ formation. 
Quantification of the median of the tail moment demon-
strated a significant ( p < 0.0001) four-fold increase follow-
ing treatment with 1  μ m etoposide for 1 h, but not after up 
to 24 h of 0.2 % O 2 (Figure 3B, upper panel). In contrast, 
 γ H2AX levels in HIF-1 α wild-type MEFs were even higher 
after 12 and 24 h of hypoxia than following treatment with 
1  μ m etoposide (Figure 3B, lower panel). Taken together, 
these data suggest that DNA-DSB is not a major determi-
nant of hypoxic  γ H2AX induction. 
 Discussion 
 Hypoxic regions in solid tumors result from an imbal-
ance between cellular oxygen consumption and oxygen 
delivery as a consequence of inefficient tumor vascula-
ture and limited oxygen diffusion (Chitneni et al. , 2011 ). 
Rapid and frequent variations in red blood cell flux cause 
temporal and spatial variations in the degree of hypoxia 
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within the same tumor. We found that chronic hypoxia 
triggers the phosphorylation of the histone variant 2AX 
in a HIF-dependent manner. In line with previous reports 
(Hammond et al. , 2003a,b ), we showed that  γ H2AX levels 
after chronic hypoxia were comparable with etoposide 
treatment. Hypoxia (0.2 % O 2 ) did not lead to detectable 
DNA damage when analyzed by alkaline single cell elec-
trophoresis. Furthermore, proliferation and cell viability 
were not altered, even after long-term (3 days) hypoxic 
exposure (data not shown). However, conditions close to 
anoxia have been reported to have direct cytotoxic effects 
and elicit apoptosis (Papandreou et al. , 2005 ). In line with 
our previous findings (Wirthner et al. , 2008 ), 53BP1 dose 
dependently accumulated in distinct nuclear foci upon 
treatment with etoposide and partially overlapped with 
 γ H2AX staining (data not shown). These foci are most 
likely sites of DNA-DSBs. In contrast, in chronic hypoxia, 
 γ H2AX did not accumulate in nuclear foci but showed a 
more diffuse pattern throughout the nucleus (data not 
shown). A similar granular  γ H2AX and ATM phospho-
S1981 staining has been reported previously to occur in 
response to severe hypoxia (0.02 % O 2 ) (Hammond et al. , 
2003a,b ; Bencokova et al. , 2009 ). Hammond et al. found 
that severe hypoxia leads to replication fork stalling and 
ATR-dependent  γ H2AX accumulation during S-phase 
(Hammond et al. , 2002, 2003a,b ). Moreover, diffuse and 
pan-nuclear  γ H2AX staining has been found to occur 
upon non-ionizing UV-C irradiation, independent of 
DNA-DSBs (Marti et al. , 2006 ). Infection with inactivated 
adeno-associated virus has been shown to lead to repli-
cation fork stalling and a diffuse  γ H2AX nuclear staining, 
which is essential for subsequent cell-cycle arrest in the 
absence of DNA damage (Fragkos et al. , 2009 ). However, 
the mechanism behind this diffuse  γ H2AX distribution 
pattern as well as its functional relevance are currently 
unknown. 
 DNA-DSBs are serious lesions that can lead to genomic 
instability if improperly repaired, or ultimately to cell death 
if the repair machinery is saturated. It is essential that the 
cell closely monitors such stress conditions and initiates 
signals for an adequate response. Phosphorylation of 
H2AX on serine 139 is established as a sensitive marker 
for DNA-DSBs (Bonner et  al. , 2008 ).  γ H2AX is regarded 
as a key component for DNA repair, even though it seems 
dispensable for the initial recognition of DNA-DSBs, and 
H2AX-deficient mice are viable (Celeste et al. , 2002, 2003 ). 
 The physiologic relevance of hypoxia-induced  γ H2AX 
is poorly understood. A recent report showed that hypoxia 
triggered neovascularization required endothelial H2AX, 
and  γ H2AX was induced in an ATR-dependent manner in 
moderate hypoxia due to replicative stress (Economopoulou 
et  al. , 2009 ). Genetic inactivation of H2AX was sufficient 
to suppress tumor angiogenesis and growth in xenograft 
models. However, this study did not address the question 
of whether HIFs are involved in this effect. In the present 
work, we were able to show that HIF is an integral factor 
required for efficient phosphorylation of H2AX under phy-
siologically relevant hypoxic conditions, and that hypoxic 
 γ H2AX induction was delayed in the absence of HIF- α . We 
previously reported that DNA-PK expression was strongly 
reduced by the absence of HIF-1 α under both normoxic and 
hypoxic conditions (Wirthner et al. , 2008 ), raising the pos-
sibility that DNA-PK might be the responsible kinase for 
H2AX phosporylation in chronic hypoxia. In line with this 
hypothesis, accumulation of DNA-PKcs, Ku70 and Ku80 
following hypoxia and iron chelation have been demon-
strated in a number of different cell lines (Ginis and Faller , 
2000 ; Lynch et al. , 2001 ; Um et al. , 2004 ; Bouquet et al. , 
2011 ). DNA-PK has been shown to phosphorylate H2AX in 
different cell lines and  in vivo in response to DNA damage 
(Stiff et al. , 2004 ; Koike et al. , 2008 ; An et al. , 2010 ) under 
hypertonic conditions (Reitsema et  al. , 2005 ) and during 
apoptotic DNA fragmentation (Mukherjee et al. , 2006 ). Of 
note, the hypoxic DNA-PK activation resulted in increased 
HIF-dependent gene expression (Bouquet et  al. , 2011 ). 
These data suggest that DNA-PK might be both upstream 
and downstream of HIF. 
 In summary, our data indicate a novel DNA-DSB inde-
pendent mechanism by which HIF downstream effec-
tors might be involved in histone H2AX phosphorylation 
during hypoxia and, hence, could contribute to therapy 
resistance of hypoxic cancer cells. 
 Materials and methods 
 Cell culture and lentiviral transduction 
 All cell lines were cultured in high glucose Dulbecco ’ s modifi ed 
Eagle ’ s medium (DMEM; Sigma, Buchs, Switzerland) as described 
previously (Stiehl et al. , 2006 ). For chronic hypoxic exposure, cells 
were grown in a gas-controlled glove box to handle the cells under 
constant oxygen (InvivO 2 400, Ruskinn Technologies, Leeds, UK). 
Before medium change, all reagents were pre-equilibrated to the 
0.2 % O 2 -containing gas mixture inside the glove box. Cell number, 
size and viability were determined by trypan blue exclusion using 
an automatic cell analyzer (Vi-Cell, Beckman-Coulter, Nyon, Swit-
zerland). Stable knockdown of HIF-1 α and HIF-2 α in HEK293 cells 
by RNA interference was achieved by lentiviral transduction of 
short hairpin (shRNA) constructs. Viral particles were produced in 
HEK293T human enbryonic kidney cells using the ViraPower lenti-
viral expression system according to the manufacturer ’ s protocol 
(Invitrogen, Basel, Switzerland) as described previously (Stiehl 
et al., 2012). 
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 Immunoblot analysis 
 Histone immunoblotting was performed as described previously 
(Wirthner et al. , 2008 ). Primary antibodies used were  γ H2AX (Milli-
pore, Zug, Switzerland), total H2AX (Millipore), and  β -actin (Sigma, 
Buchs, Switzerland). Horseraddish-peroxidase-coupled secondary 
anti-mouse and anti-rabbit antibodies were purchased from Pierce 
(Lausanne, Switzerland). Chemiluminescence detection was per-
formed using Supersignal West Dura (Pierce), and signals were re-
corded and quantifi ed using a charge-coupled device camera (Lighti-
mager LAS-4000mini, Fujufi lm, Dielsdorf, Switzerland). Extracted 
histones were stained with Ponceau S (Sigma). 
 Flow cytometry 
 Single cell suspensions were incubated with an antibody against 
 γ H2AX and propidium iodide (PI) according to the manufacturer ’ s 
instructions. Stained cells were analyzed with a FACSCanto II utiliz-
ing FACSDiva soft ware (BD Biosciences, Allschwil, Switzerland). 
 Single cell electrophoresis (comet assays) 
 Alkaline single cell electrophoresis was performed as described 
 before (Wirthner et al. , 2008 ). Briefl y, MEFs were mixed with 0.5 % 
low-melting-point agarose (Sigma), solidifi ed on microscopy slides 
and lysed with 1 % Triton-X100, 2.5  m NaCl, 100 m m EDTA, 10 m m 
 Tris-HCl (pH 10.0) for 1 h at 4 ° C in the absence of light. Horizontal 
electrophoresis ( ∼ 0.74 V/cm; 300 mA) was performed in 300 m m 
NaOH, 1 m m EDTA for 30 min. Following SYBR green (Invitrogen) 
staining, DNA migration was visualized by fl uorescence microscopy, 
and the tail moment ( % DNA in the tail multiplied by the tail length) 
was calculated from  > 150 cells per condition using the CometScore 
soft ware package (TriTek, Sumerduck, VA, USA). Quantifi cation of 
the median tail moments is shown as mean values  ± standard error 
of the mean (SEM). Statistical analysis was performed applying two-
tailed Student ’ s t - test using GraphPad Prism version 4.0 (GraphPad 
Soft ware, Ja Jolla, CA, USA). 
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